| European Case Law Identifier: | ECLI:EP:BA:2015:T167311.20151020 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 20 October 2015 | ||||||||
| Case number: | T 1673/11 | ||||||||
| Application number: | 99965162.3 | ||||||||
| IPC class: | C12N 9/24 A01N 37/18 A61K 38/43 A61P 3/00 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | TREATMENT OF POMPE'S DISEASE | ||||||||
| Applicant name: | Genzyme Corporation | ||||||||
| Opponent name: | ZyStor Therapeutics , Inc. Lingner, Margrit |
||||||||
| Board: | 3.3.02 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Article 123(3) EPC: Change from a claim under the provisions of the EPC 1973 invoking the legal fiction according to G 5/83to a claim under the provisions of Article 54(5) EPC 2000 (not allowable) | ||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t111673eu1.html
Date retrieved: 17 May 2021